Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons - PubMed (original) (raw)

Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons

Ian R Wickersham et al. Neuron. 2007.

Abstract

There has never been a wholesale way of identifying neurons that are monosynaptically connected either to some other cell group or, especially, to a single cell. The best available tools, transsynaptic tracers, are unable to distinguish weak direct connections from strong indirect ones. Furthermore, no tracer has proven potent enough to label any connected neurons whatsoever when starting from a single cell. Here we present a transsynaptic tracer that crosses only one synaptic step, unambiguously identifying cells directly presynaptic to the starting population. Based on rabies virus, it is genetically targetable, allows high-level expression of any gene of interest in the synaptically coupled neurons, and robustly labels connections made to single cells. This technology should enable a far more detailed understanding of neural connectivity than has previously been possible.

PubMed Disclaimer

Figures

Figure 1

Figure 1. Transcomplemented Transsynaptic Tracing

(A) A deletion mutant tracing virus missing one or more genes required for transsynaptic spread, as well as the separate missing viral gene(s), are introduced into a cell or cell type of interest. Both the initial infection and the complementing viral genes must be restricted to the neuronal population of interest. (B) Because all viral genes are present in the initially infected population, the virus can spread transsynaptically to cells in direct synaptic contact with them. Since the missing viral genes are not present in these cells, however, the virus cannot spread further. (C) The rabies virion. The viral core consists of the RNA genome and associated proteins and is surrounded by a host-cell-derived membrane in which is embedded the rabies virus glycoprotein (G). The EGFP gene was substituted for that of the glycoprotein within the viral genome (center). Versions of this virus can be made that incorporate either its native glycoprotein (designated SADΔG-EGFP, right, top) or the glycoprotein of some other virus. In this study the rabies virus was pseudotyped with the glycoprotein from ASLV-A, termed EnvA, and this virus is designated SADΔG-EGFP(EnvA) (right, bottom). (D) Targeting infection. ASLV-A-pseudotyped rabies virus [SADΔG-EGFP(EnvA)] can’t infect mammalian neurons unless the gene for ASLV-A’s receptor, TVA, has been introduced into them. This causes the receptor to be expressed on the cells’ surface, allowing infection by the pseudotyped virus. Therefore, the basic requirements of the system are as follows. First insert two genes into the cell or cell type of interest: the gene for TVA, so the virus can enter, and the gene for the rabies virus glycoprotein, so the virus can spread to synaptically coupled cells. Then apply the ASLV-A-pseudotyped virus. (E) Following these steps, there is specific infection of the TVA-expressing cell; complementation with the rabies virus glycoprotein allows the virus to spread to directly presynaptic neurons. These cells all express the EGFP encoded in the viral genome, but the virus cannot spread beyond these directly connected cells because they do not express the viral glycoprotein.

Figure 2

Figure 2. Selective Infection and In Situ Complementation in Slice Culture

(A–D) Initial infection is restricted to cells expressing the ASLV-A receptor, TVA. In these control experiments to test infection selectivity, isolated neurons in cultured brain slices were transfected using the gene gun with two genes, one encoding TVA, and the other, DsRed2. ASLV-A-pseudotyped rabies virus [SADΔG-EGFP(EnvA)] was applied the next day and images were taken 6 days following. (A and C) DsRed2 expression marking transfection with TVA and (B and D) EGFP expression indicating subsequent selective infection of the same TVA-expressing cells with pseudotyped virus. (E–H) In situ complementation permits transsynaptic spread from a single initially infected cell to a cluster of monosynaptically connected cells. Isolated neurons were transfected with three genes encoding TVA to permit viral infection, DsRed2 to mark transfected cells, and the rabies virus glycoprotein gene to complement the deletion in the viral genome. (E) DsRed2 fluorescence indicating a transfected cell, marked with a dotted line, at the center of the cluster shown in (F). (G and H) Two more examples of clusters surrounding a single transfected cell. The initially infected cells expressing both EGFP and DsRed2 appear yellow. Scale bars: 200 μm.

Figure 3

Figure 3. More Examples of Transcomplemented Tracing

(A–C) Long-range viral spread from a single initially infected cell. (A) A huge cluster of green cells surrounds a single red/green deep-layer cortical neuron (dotted line) at 8 days postinfection. Another dense cluster of cells is also infected in the superficial cortical layers immediately above it, consistent with known projections of superficial layers to deeper ones; distant deep-layer pyramidal cells are also infected, again consistent with known patterns of long-range intralaminar connectivity. To the left of the putatively initially infected cell is a second yellow (double-labeled) cell, apparently secondarily—and recently—infected because of the lack of green cells surrounding it. (B–C) Closeup of central cluster from (A). (D–F) More examples of in situ complementation: clusters of infected cells surrounding isolated putatively postsynaptic ones. Scale bars: 200 μm.

Figure 4

Figure 4. Viral Spread Is Specific to Cells Presynaptic to the Initially Infected Cell

(A) DIC image of slice and recording pipettes targeting putatively pre- and postsynaptic neurons, (B) combined fluorescent image, and (C–D) single-channel fluorescence images. (E) Inhibitory postsynaptic currents in the putatively postsynaptic cell are coincident with action potentials in a nearby infected one, demonstrating a monosynaptic connection. (F–J) Similar demonstration of spread to an excitatory pre-synaptic cell. Scale bar: 100 μm, applies to all panels.

Similar articles

Cited by

References

    1. Barnard RJ, Elleder D, Young JA. Avian sarcoma and leukosis virus-receptor interactions: from classical genetics to novel insights into virus-cell membrane fusion. Virology. 2006;344:25–29. - PubMed
    1. Bates P, Young JA, Varmus HE. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell. 1993;74:1043–1051. - PubMed
    1. Boerger AL, Snitkovsky S, Young JA. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci USA. 1999;96:9867–9872. - PMC - PubMed
    1. Borrell V, Yoshimura Y, Callaway EM. Targeted gene delivery to telencephalic inhibitory neurons by directional in utero electroporation. J Neurosci Methods. 2005;143:151–158. - PubMed
    1. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci. 2005;8:1263–1268. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources